合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 2-nitroimidazole (I) with methyl chloroacetate (II) by means of sodium methoxide in hot DMF gives methyl (2-nitro-1-imidazolyl)acetate (III), which is then treated with ethanolamine (IV) in methanol.
【1】
Castaner, J.; Robinson, C.; Etanidazole. Drugs Fut 1995, 20, 8, 772.
|
【2】
Lee, W.W.; Brown, J.M.; Martinez, A.P.; Cory, M.J. (US Department of Health & Human Services); Nitroimidazoles of low toxicity and high activity as radiosensitizers of hypoxic tumor cells. US 4371540 .
|
【3】
Beaman, A.G.; Duschinsky, R.; Tautz, W.P. (F. Hoffmann-La Roche AG); 2-Nitroimidazoles. US 3679698 .
|
【4】
Beaman, A.G.; Duschinsky, R.; Tautz, W.P. (F. Hoffmann-La Roche AG); Novel imidazole derivs. and a process for the manufacture thereof. GB 1138529 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
10258 |
methyl 2-(2-nitro-1H-imidazol-1-yl)acetate; Methyl 2-nitro-1-imidazoleacetate
|
22813-31-6 |
C6H7N3O4 |
详情 | 详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(XI) In a further process, the racemic trans glycidic ester (XII), prepared by Darzen's condensation between anisaldehyde (X) and methyl chloroacetate (XI), was resolved by enantioselective enzymatic hydrolysis, using several different enzymes and reaction conditions to produce the undesired (2S,3R) acid (XIII), while leaving intact the required (2R,3S)-glycidic ester (XIV) (4-7). Opening of the chiral epoxide (XIV) with 2-aminobenzenethiol (VII) proceeded with retention of the configuration, producing methyl (2S,3S)-2-hydroxy-3-(2-aminophenylsulfanyl)-3-(4-methoxyphenyl)propionate (XV) (8). Alternatively, the (S,S)-amino ester (XV) was obtained by resolution with tartaric acid of the racemic three-adduct resulting from epoxide (XII) and 2-aminobenzenethiol (VII) (9). Cyclization of amino ester (XV) in refluxing xylene in the presence of p-toluenesulfonic acid afforded the target lactam (VIII) (9). The cyclization of (XV) to lactam (VIII) was also accomplished by means of trichloroacetic acid or under basic conditions
【1】
Bhushan, L.B.; Jayachandran, B.E.; Bhushan, L.V.; Thottappillil, R. (Council of Scientific and Industrial Research); Process for preparing diltiazem. US 5869697 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
25182 |
2-aminobenzenethiol
|
137-07-5 |
C6H7NS |
详情 | 详情
|
(VIII) |
62436 |
(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C16H15NO3S |
详情 |
详情
|
(X) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(XI) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(XII) |
11905 |
methyl (2R,3S)-3-(4-methoxyphenyl)-2-oxiranecarboxylate
|
|
C11H12O4 |
详情 |
详情
|
(XIII) |
62438 |
(2R,3S)-3-(4-methoxyphenyl)-2-oxiranecarboxylic acid
|
|
C10H10O4 |
详情 |
详情
|
(XIV) |
62435 |
ethyl (2R,3S)-3-(4-methoxyphenyl)-2-oxiranecarboxylate
|
|
C12H14O4 |
详情 |
详情
|
(XV) |
62439 |
methyl (2S,3S)-3-[(2-aminophenyl)sulfanyl]-2-hydroxy-3-(4-methoxyphenyl)propanoate
|
|
C17H19NO4S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VIII) Several related procedures utilize racemic intermediates that are resolved in more advanced synthetic steps. The racemic trans-glycidic ester (IX) was prepared by Darzen's condensation between anisaldehyde (VII) and methyl chloroacetate (VIII). Opening of the epoxide group of (IX) with 2-aminothiophenol (X) in hot chlorobenzene in the presence of FeCl3 gave rise to the racemic threo adduct (XI) which, without isolation, was cyclized to the cis-lactam (XII) by addition of methanesulfonic acid and then heating to reflux. Alkylation of the lactam N of (XII) with 2-(dimethylamino)ethyl chloride (II) led to the racemic precursor (XIII). Resolution of (XIII) to provide the (S,S)-isomer (VII) was then accomplished by preferential crystallization of supersaturated solutions of several sulfonate salts of (XIII) upon seeding with the desired enantiomer. Racemic diltiazem (XIV), obtained by acetylation of (XIII), has been resolved via formation of the corresponding diastereoisomeric salts with (S)-naproxen
【1】
Gizur, T.; Harsanyi, K.; Fogassy, E.; Studies of the resolution of racemates in the synthesis of diltiazem. J Prakt Chem Chem-Ztg 1994, 336, 7, 628.
|
【2】
Yamada, S.; Yoshioka, R.; Shibatani, T.; Optical resolution of a 1,5-benzothiazepine derivative,a synthetic intermediate of diltiazem, by preferential crystallization and diastereomeric salt formation. Chem Pharm Bull 1997, 45, 12, 1922.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
11907 |
Dimethylaminoethyl chloride; 2-Dimethylaminoethyl chloride; 2-Chloro-N,N-dimethyl-1-ethanamine; N-(2-Chloroethyl)-N,N-dimethylamine
|
107-99-3 |
C4H10ClN |
详情 | 详情
|
(VII) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(VII) |
62488 |
(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C20H24N2O3S |
详情 |
详情
|
(VIII) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(IX) |
11905 |
methyl (2R,3S)-3-(4-methoxyphenyl)-2-oxiranecarboxylate
|
|
C11H12O4 |
详情 |
详情
|
(X) |
25182 |
2-aminobenzenethiol
|
137-07-5 |
C6H7NS |
详情 | 详情
|
(XI) |
62439 |
methyl (2S,3S)-3-[(2-aminophenyl)sulfanyl]-2-hydroxy-3-(4-methoxyphenyl)propanoate
|
|
C17H19NO4S |
详情 |
详情
|
(XII) |
62436 |
(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C16H15NO3S |
详情 |
详情
|
(XIII) |
62487 |
5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C20H24N2O3S |
详情 |
详情
|
(XIV) |
62489 |
5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
|
|
C22H26N2O4S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VI) Several novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), a key intermediate in the synthesis of losartan, have been described:
1) Treatment of glycine methyl ester hydrochloride (I) with NaOH in methanol, followed by reaction with methyl pentanimidate (II), gives 2-butyl-4,5-dihydro-1H-imidazol-5-one (III), which is treated with POCl3 to give the 2-butyl-5-chloro-1H-imidazole (IV). Reaction of (IV) with POCl3 and DMF yields the enamine (V), which is finally hydrolyzed with water to 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), the desired intemediate in the synthesis of losartan.
2) Imidazolinone (III) can also be obtained by cyclization of chloroacetic acid methyl ester (VI), chloroacetyl chloride (VII) or bromoacetyl bromide (VIII) with pentanamidine (IX) by means of NaOH in methanol.
3) Alternatively, imidazolinone (III) can be treated with dimethylformamide dimethylacetal in dichloromethane yielding the enamine (X), which is finally treated with POCl3 and hydrolyzed with water.
4) The reaction of glycine (XI) with methyl pentanimidate (II) in NaOH/MeOH gives amidine (XII), which, without isolation, is treated with POCl3 and DMF at 100 C for 2 h, and then hydrolyzed with water to give the desired 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde.
Methyl pentanimidate (II) is obtained treating a solution of valeronitrile in MeOH with HCl gas followed by neutralization with aqueous KOH and extraction with Et2O.
【1】
Kohr, J.; Griffiths, G.J.; Imwinkelried, R.; Hauck, M.B.; Roten, C.A.; Stucky, G.C.; Novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde: A key intermediate for the synthesis of the angiotensin II antagonist losartan. J Org Chem 1999, 64, 22, 8084. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(II) |
34050 |
methyl pentanimidoate
|
|
C6H13NO |
详情 |
详情
|
(III) |
34051 |
2-butyl-3,5-dihydro-4H-imidazol-4-one
|
|
C7H12N2O |
详情 |
详情
|
(IV) |
34052 |
2-butyl-5-chloro-1H-imidazole
|
|
C7H11ClN2 |
详情 |
详情
|
(V) |
34053 |
N-[(2-butyl-5-chloro-4H-imidazol-4-ylidene)methyl]-N,N-dimethylamine; (2-butyl-5-chloro-4H-imidazol-4-ylidene)-N,N-dimethylmethanamine
|
|
C10H16ClN3 |
详情 |
详情
|
(VI) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(VII) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(VIII) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IX) |
14576 |
pentanimidamide
|
109-51-3 |
C5H12N2 |
详情 | 详情
|
(X) |
34054 |
2-butyl-5-[(E)-(dimethylamino)methylidene]-3,5-dihydro-4H-imidazol-4-one
|
|
C10H17N3O |
详情 |
详情
|
(XI) |
13925 |
2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde
|
83857-96-9 |
C8H11ClN2O |
详情 | 详情
|
(XII) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XIII) |
34055 |
2-(pentanimidoylamino)acetic acid
|
|
C7H14N2O2 |
详情 |
详情
|
(XIV) |
13921 |
Pentanenitrile; n-Valeronitrile
|
110-59-8 |
C5H9N |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(XI) The condensation of 5(S)-(trityloxymethyl)-2-pyrrolidinone (I) with benzyl chloroformate (II) and BuLi in THF gives the carbamate (III), which is alkylated with tert-butyl 2-chloroacetate (IV) and LHMDS in THF to yield 2-[1-(benzyloxycarbonyl)-2-oxo-5(S)-(trityloxymethyl)pyrrolidin-2(S)-yl]acetic acid tert-butyl ester (V). The hydrogenation of (V) with H2 over Pd/C in hot tert-butanol affords 2-[5(S)-(hydroxymethyl)-2-oxopyrrolidin-2(S)-yl]acetic acid tert-butyl ester (VI), which is treated with MsCl and TEA in dichloromethane to provide the methanesulfonate (VII). The condensation of (VII) with 4'-hydroxybiphenyl-4-carbonitrile (VIII) by means of potassium tert-butoxide in DMF gives the adduct (IX), which by treatment with HCl in methanol, and with ammonia in the same solvent yields 2-[5(S)-(4'-amidinobiphenyl-4-yloxymethyl)-2-oxopyrrolidin-3(S)-yl]acetic acid methyl ester (X). Finally, this compound is condensed with methyl chloroformate (XI) by means of NaOH in dichloromethane to afford the target compound.
【1】
Himmelsbach, F.; Austel, V.; Pieper, H.; Eisert, W.; Müller, T.; Weisenberger, J.; Linz, G.; Krüger, G. (Dr. Karl Thomae GmbH); Cyclic imino derivs., process for their preparation and drugs containing them. DE 4035961; EP 0483667; JP 1992264068; US 5591769 . |
【2】
Himmelsbach, F.; Austel, V.; Pieper, H.; Linz, G.; Wisenberger, J.; Muller, T. (Dr. Karl Thomae GmbH); Cyclic imino derivs., medicaments containing these cpds. and processes for the production thereof. DE 4213919; EP 0567966; JP 1994073001 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48730 |
(S)-(+)-5-(Trityloxymethyl)-2-pyrrolidinone
|
|
C24H23NO2 |
详情 |
详情
|
(II) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(III) |
48731 |
benzyl (5S)-2-oxo-5-[(trityloxy)methyl]-1-pyrrolidinecarboxylate
|
|
C32H29NO4 |
详情 |
详情
|
(IV) |
40664 |
tert-butyl 2-chloroacetate
|
107-59-5 |
C6H11ClO2 |
详情 | 详情
|
(V) |
48732 |
benzyl (3S,5S)-3-[2-(tert-butoxy)-2-oxoethyl]-2-oxo-5-[(trityloxy)methyl]-1-pyrrolidinecarboxylate
|
|
C38H39NO6 |
详情 |
详情
|
(VI) |
48733 |
tert-butyl 2-[(3S,5S)-5-(hydroxymethyl)-2-oxopyrrolidinyl]acetate
|
|
C11H19NO4 |
详情 |
详情
|
(VII) |
48734 |
tert-butyl 2-((3S,5S)-5-[[(methylsulfonyl)oxy]methyl]-2-oxopyrrolidinyl)acetate
|
|
C12H21NO6S |
详情 |
详情
|
(VIII) |
48735 |
4-Cyano-4'-hydroxybiphenyl; 4-Hydroxy-4'-cyanodiphenyl; 4'-Cyano-4-biphenylol; 4'-Hydroxy-4-biphenylcarbonitrile
|
19812-93-2 |
C13H9NO |
详情 | 详情
|
(IX) |
48736 |
tert-butyl 2-((3S,5S)-5-[[(4'-cyano[1,1'-biphenyl]-4-yl)oxy]methyl]-2-oxopyrrolidinyl)acetate
|
|
C24H26N2O4 |
详情 |
详情
|
(X) |
48737 |
methyl 2-[(3S,5S)-5-[([4'-[amino(imino)methyl][1,1'-biphenyl]-4-yl]oxy)methyl]-2-oxopyrrolidinyl]acetate
|
|
C21H23N3O4 |
详情 |
详情
|
(XI) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The Darzen's condensation of 4-iodoacetophenone (I) with methyl chloroacetate (II) in the presence of NaOMe afforded the glycidic ester (III), which was further hydrolyzed to the corresponding glycidic acid (IV) with NaOH in aqueous ethanol. Subsequent decarboxylation of (IV) under acidic conditions furnished 2-(4-iodophenyl)propionaldehyde (V). After oxidation of aldehyde (V) with sodium chlorite, the resultant carboxylic acid was converted to the corresponding zinc salt (VI) upon treatment with ZnCl2 and NaOH. Coupling of aryl iodide (VI) with the Grignard reagent (VIII) (prepared from 2-bromo-3-methylthiophene (VII)) in the presence of PdCl2 gave rise to the racemic biarylpropionic acid (IX)). The title (R)-enantiomer was then resolved via formation of the diastereoisomeric salts with D-phenylglycine methyl ester (X)
【2】
Arai, H.; Tanaka, K.; Watanabe, I.; Kodama, T.; Hirano, H.; Abe, N.; Nakabayashi, M. (Toyama Chemical Co., Ltd.); Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain. US 4230719 . |
【1】
Kodama, T.; Nakabayashi, M.; Watanabe, I.; Hirano, Y.; Abe, N.; Tanaka, K.; Arai, H. (Toyama Chemical Co., Ltd.); 2-[4-(3-Methyl-2-thienyl)phenyl]propionic acid derivs. and its non-toxic salts. DE 2850485; JP 1981049376 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51497 |
4'-Iodoacetophenone; 4-Iodoacetophenone; 1-(4-Iodophenyl)ethanone
|
13329-40-3 |
C8H7IO |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
62683 |
methyl 3-(4-iodophenyl)-3-methyl-2-oxiranecarboxylate
|
|
C11H11IO3 |
详情 |
详情
|
(IV) |
62684 |
3-(4-iodophenyl)-3-methyl-2-oxiranecarboxylic acid
|
|
C10H9IO3 |
详情 |
详情
|
(V) |
62685 |
2-(4-iodophenyl)propanal
|
|
C9H9IO |
详情 |
详情
|
(VI) |
62686 |
|
|
C18H16I2O4Zn |
详情 |
详情
|
(VII) |
12443 |
2-Bromo-3-methylthiophene
|
14282-76-9 |
C5H5BrS |
详情 | 详情
|
(VIII) |
36973 |
bromo(3-methyl-2-thienyl)magnesium
|
|
C5H5BrMgS |
详情 |
详情
|
(IX) |
62687 |
2-[4-(3-methyl-2-thienyl)phenyl]propanoic acid
|
|
C14H14O2S |
详情 |
详情
|
(X) |
10717 |
methyl (2S)-2-amino-2-phenylethanoate
|
|
C9H11NO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) Preparation of the racemic arylpropionic acid (IX) has been reported through a number of different procedures. 4-Aminoacetophenone (XI) was diazotized to (XII) employing isoamyl nitrite and either acetic or fluoboric acid. Then, the Gomberg-Bachmann coupling of diazonium salt (XII) with 3-methylthiophene (XIII) furnished 4-(3-methyl-2-thienyl)acetophenone (XIV). Subsequent Darzen's condensation of acetophenone (XIV) with methyl chloroacetate (II) afforded the glycidic ester (XV), which was further hydrolyzed to acid (XVI), and then decarboxylated to aldehyde (XVII). Oxidation of (XVII) to the key carboxylic acid was performed by treatment with potassium permanganate
【2】
Arai, H.; Tanaka, K.; Watanabe, I.; Kodama, T.; Hirano, H.; Abe, N.; Nakabayashi, M. (Toyama Chemical Co., Ltd.); Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain. US 4230719 . |
【1】
Kodama, T.; Nakabayashi, M.; Watanabe, I.; Hirano, Y.; Abe, N.; Tanaka, K.; Arai, H. (Toyama Chemical Co., Ltd.); 2-[4-(3-Methyl-2-thienyl)phenyl]propionic acid derivs. and its non-toxic salts. DE 2850485; JP 1981049376 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(IX) |
62687 |
2-[4-(3-methyl-2-thienyl)phenyl]propanoic acid
|
|
C14H14O2S |
详情 |
详情
|
(XI) |
27847 |
1-(4-aminophenyl)-1-ethanone
|
99-92-3 |
C8H9NO |
详情 | 详情
|
(XII) |
62688 |
4-acetylbenzenediazonium
|
|
C8H7N2O |
详情 |
详情
|
(XIII) |
12442 |
3-Methylthiophene
|
616-44-4 |
C5H6S |
详情 | 详情
|
(XIV) |
62689 |
1-[4-(3-methyl-2-thienyl)phenyl]-1-ethanone
|
|
C13H12OS |
详情 |
详情
|
(XV) |
62690 |
methyl 3-methyl-3-[4-(3-methyl-2-thienyl)phenyl]-2-oxiranecarboxylate
|
|
C16H16O3S |
详情 |
详情
|
(XVI) |
62691 |
3-methyl-3-[4-(3-methyl-2-thienyl)phenyl]-2-oxiranecarboxylic acid
|
|
C15H14O3S |
详情 |
详情
|
(XVII) |
62692 |
2-[4-(3-methyl-2-thienyl)phenyl]propanal
|
|
C14H14OS |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of ethyl chloroacetate (I) with ethyl formate (II) by means of potassium tert-butoxide in diisopropyl ether gives the 2-formylchloroacetate (III), which is cyclized with 6-methylpyridine-2-amine (IV) by means of conc. H2SO4, yielding 5-methylimidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester (V). The chlorination of (V) with NCS in THF affords the chloromethyl derivative (VI), which is condensed with the monoprotected diamine (VII) by means of TEA to provide the adduct (VIII). The cyclization of (VIII) by means of NaOMe, TEA and NaI in DMF gives 4-[4-(benzyloxycarbonylamino)butyl]-4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one (IX), which is deprotected with H2 over Pd/C in MeOH, yielding the butylamine derivative (X). Finally, this compound is sulfonated with N-phenyltrifluoromethylsulfonimide (XI) and TEA in DMF.
【1】
Ikemoto, T.; et al.; A practical synthesis of the chronic renal disease agent, 4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one derivatives, using regioselective chlorination of ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxy with N-chlorosuccinimide. Tetrahedron 2000, 56, 40, 7915. |
【2】
Takatani, M.; Shibouta, Y.; Tomimatsu, K.; Kawamoto, T. (Takeda Chemical Industries, Ltd.); Tricyclic cpds., their production and use. EP 0771319; JP 1996081467; WO 9602542 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(II) |
16602 |
ethyl formate
|
109-94-4 |
C3H6O2 |
详情 | 详情
|
(III) |
16600 |
ethyl 2-chloro-3-oxopropanoate
|
|
C5H7ClO3 |
详情 |
详情
|
(IV) |
19678 |
6-methyl-2-pyridinamine; 6-methyl-2-pyridinylamine; 6-amino-2-picoline; 2-Amino-6-methylpyridine
|
1824-81-3 |
C6H8N2 |
详情 | 详情
|
(V) |
42075 |
ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate
|
|
C11H12N2O2 |
详情 |
详情
|
(VI) |
42076 |
ethyl 5-(chloromethyl)imidazo[1,2-a]pyridine-3-carboxylate
|
|
C11H11ClN2O2 |
详情 |
详情
|
(VII) |
42077 |
benzyl 4-aminobutylcarbamate
|
62146-62-7 |
C12H18N2O2 |
详情 | 详情
|
(VIII) |
42078 |
ethyl 5-[[(4-[[(benzyloxy)carbonyl]amino]butyl)amino]methyl]imidazo[1,2-a]pyridine-3-carboxylate
|
|
C23H28N4O4 |
详情 |
详情
|
(IX) |
42079 |
benzyl 4-(3-oxo-3,5-dihydro-4H-1,4,8b-triazaacenaphthylen-4-yl)butylcarbamate
|
|
C21H22N4O3 |
详情 |
详情
|
(X) |
42080 |
4-(4-aminobutyl)-4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one
|
|
C13H16N4O |
详情 |
详情
|
(XI) |
17573 |
N-Phenyltrifluoromethanesulfonimide; Trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide
|
37595-74-7 |
C8H5F6NO4S2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) Alkylation of 7-hydroxyindole (I) with methyl chloroacetate (II) provided indolyl ether (III). Conjugate addition of 2-nitropropene (IV) to indole (III) in refluxing benzene, afforded the 3-(2-nitropropyl)indole (V), which was further reduced to the corresponding amine (VI) by catalytic hydrogenation over Raney nickel. Ring opening of the chiral epoxide (VII) with the racemic amine (VI) gave rise to a diastereomeric mixture of amino alcohols (VIII). After isolation of the desired (R,R)-isomer by column chromatography, basic hydrolysis of the methyl ester function yielded the title carboxylic acid.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIIIa) |
56159 |
methyl 2-{[3-((2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)-1H-indol-7-yl]oxy}acetate
|
|
C22H25ClN2O4 |
详情 |
详情
|
(VIIIb) |
56160 |
methyl 2-{[3-((2S)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)-1H-indol-7-yl]oxy}acetate
|
|
C22H25ClN2O4 |
详情 |
详情
|
(I) |
56154 |
7-Hydroxyindole; 7-Indolol
|
2380-84-9 |
C8H7NO |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
56155 |
methyl 2-(1H-indol-7-yloxy)acetate
|
|
C11H11NO3 |
详情 |
详情
|
(IV) |
56156 |
2-nitro-1-propene
|
|
C3H5NO2 |
详情 |
详情
|
(V) |
56157 |
methyl 2-{[3-(2-nitropropyl)-1H-indol-7-yl]oxy}acetate
|
|
C14H16N2O5 |
详情 |
详情
|
(VI) |
56158 |
methyl 2-{[3-(2-aminopropyl)-1H-indol-7-yl]oxy}acetate
|
|
C14H18N2O3 |
详情 |
详情
|
(VII) |
15271 |
(R)-(+)-3-Chlorostyrene oxide; (2R)-2-(3-Chlorophenyl)oxirane
|
62600-71-9 |
C8H7ClO |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(IX) A pilot plant process was further developed for the (S)-enantiomer. Darzens condensation of benzophenone (VIII) with methyl chloroacetate gave the glycidic ester (X). Epoxide opening in (X) with trimethylaluminum furnished methyl 2-hydroxy-3,3-diphenylbutyrate (XI), which was hydrolyzed to the corresponding acid (VI) by using KOH in isopropanol. Treatment of the racemic acid (VI) with (S)-1-(4-chlorophenyl)ethylamine (XII) provided the desired (S)-acid salt (XIII). This was finally condensed with 4,6-dimethyl-2-(methylsulfonyl)pyrimidine (XIV) in the presence of lithium amide to yield the title compound.
【1】
Jansen, R.; et al.; Structural similarity and its suprises: Endothelin receptor antagonists - Process research and development report. Org Process Res Dev 2001, 5, 1, 16.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
48526 |
2-hydroxy-3,3-diphenylbutyric acid
|
|
C16H16O3 |
详情 |
详情
|
(VIII) |
18732 |
benzophenone
|
119-61-9 |
C13H10O |
详情 | 详情
|
(IX) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(X) |
21148 |
methyl 3,3-diphenyl-2-oxiranecarboxylate
|
|
C16H14O3 |
详情 |
详情
|
(XI) |
48528 |
methyl 2-hydroxy-3,3-diphenylbutanoate
|
|
C17H18O3 |
详情 |
详情
|
(XII) |
48529 |
(S)-4-Chloro-alpha-methylbenzylamine; 1-(4-Chlorophenyl)ethylamine
|
4187-56-8 |
C8H10ClN |
详情 | 详情
|
(XIII) |
48530 |
(1S)-1-(4-chlorophenyl)-1-ethanaminium (2S)-2-hydroxy-3,3-diphenylbutanoate
|
|
C24H26ClNO3 |
详情 |
详情
|
(XIV) |
38714 |
4,6-dimethyl-2-(methylsulfonyl)pyrimidine; 4,6-dimethyl-2-pyrimidinyl methyl sulfone
|
|
C7H10N2O2S |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) The condensation of benzophenone (I) with methyl 2-chloroacetate (II) by means of NaOMe in THF gives 3,3-diphenyloxirane-2-carboxylic acid methyl ester (III), which by treatment with BF3/Et2O and methanol, followed by optical resolution, yielded the pure enantiomer 2(S)-hydroxy-3-methoxy-3,3-diphenylpropionic acid methyl ester (IV). The condensation of (IV) with 4,6-dimethyl-2-(methylsulfonyl)pyrimidine (V) by means of K2CO3 in DMF affords 2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid methyl ester (VI), which is finally hydrolyzed with KOH in hot dioxane to afford the target propionic acid as a racemic mixture.
【1】
Riechers, H.; Albrecht, H.-P.; Amberg, W.; et al.; Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J Med Chem 1996, 39, 11, 2123.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18732 |
benzophenone
|
119-61-9 |
C13H10O |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
21148 |
methyl 3,3-diphenyl-2-oxiranecarboxylate
|
|
C16H14O3 |
详情 |
详情
|
(IV) |
38710 |
methyl (2S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoate
|
|
C17H18O4 |
详情 |
详情
|
(V) |
38714 |
4,6-dimethyl-2-(methylsulfonyl)pyrimidine; 4,6-dimethyl-2-pyrimidinyl methyl sulfone
|
|
C7H10N2O2S |
详情 |
详情
|
(VI) |
56710 |
methyl (2S)-2-[(4,6-dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoate
|
|
C23H24N2O4 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) Treatment of salicylaldehyde (I) with methyl chloroacetate (II) in DMF in the presence of potassium carbonate provides methyl o-formylphenoxyacetate (III), which is converted into methyl 2-benzofuranecarboxylate (IV) by reaction with DBU in toluene. Reduction of (IV) by means of LiAlH4 in ether yields hydroxy derivative (V), which then reacts with SOCl2 in ether/DMF to furnish chloro derivative (VI). Treatment of (VI) with NaCN in DMSO affords cyano derivative (VII), which is converted into 2-benzofuraneacetic acid (VIII) by treatment with NaOH in boiling water. Esterification of (VIII) by treatment with HCl in refluxing MeOH affords methyl acetate derivative (IX), which is condensed with p-anisoyl chloride (X) by means of SnCl4 in 1,2-dichloroethane to yield compound (XI). Treatment of (XI) with aluminum powder and iodine crystals (to generate AlI3) in refluxing benzene gives acetic acid derivative (XII), which is iodinated with iodine and K2CO3 in H2O to give derivative (XIII). Esterification of (XIII) by means of iPrOH and H2SO4 provides isopropyl acetate derivative (XIV), which is finally converted into the desired product by reaction with diethylaminoethyl chloride (XV) in NaOH and CH2Cl2 in the presence of benzyltriethylammonium chloride.
【1】
Druzgala, P. (ARYx Therapeutics, Inc.); Benzoylbenzofurane derivs. for treatment of cardiac arrhythmia. EP 0703910; JP 1996511546; US 5364880; WO 9429289 .
|
【2】
Druzgala, P. (ARYx Therapeutics, Inc.); Cpd. for treatment of cardiac arrhythmia, synthesis, and methods of use. US 5849788 .
|
【3】
Druzgala, P. (ARYx Therapeutics, Inc.); Cpd. for treatment of cardiac arrhythmia, synthesis, and methods of use. US 6130240 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21351 |
2-Hydroxybenzaldehyde;Salicylic aldehyde;2-Formylphenol;salicylaldehyde |
90-02-8 |
C7H6O2 |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
49708 |
methyl 2-(2-formylphenoxy)acetate
|
|
C10H10O4 |
详情 |
详情
|
(IV) |
49709 |
methyl 1-benzofuran-2-carboxylate
|
|
C10H8O3 |
详情 |
详情
|
(V) |
38335 |
1-benzofuran-2-ylmethanol
|
|
C9H8O2 |
详情 |
详情
|
(VI) |
49710 |
2-(chloromethyl)-1-benzofuran
|
|
C9H7ClO |
详情 |
详情
|
(VII) |
38336 |
2-(1-benzofuran-2-yl)acetonitrile
|
|
C10H7NO |
详情 |
详情
|
(VIII) |
49711 |
2-(1-benzofuran-2-yl)acetic acid
|
|
C10H8O3 |
详情 |
详情
|
(IX) |
49712 |
methyl 2-(1-benzofuran-2-yl)acetate
|
|
C11H10O3 |
详情 |
详情
|
(X) |
22671 |
4-Methoxybenzoyl chloride; p-Methoxybenzoyl chloride; 4-Anisoyl chloride
|
100-07-2 |
C8H7ClO2 |
详情 | 详情
|
(XI) |
49713 |
methyl 2-[3-(4-methoxybenzoyl)-1-benzofuran-2-yl]acetate
|
|
C19H16O5 |
详情 |
详情
|
(XII) |
49714 |
2-[3-(4-hydroxybenzoyl)-1-benzofuran-2-yl]acetic acid
|
|
C17H12O5 |
详情 |
详情
|
(XIII) |
49715 |
2-[3-(4-hydroxy-3,5-diiodobenzoyl)-1-benzofuran-2-yl]acetic acid
|
|
C17H10I2O5 |
详情 |
详情
|
(XIV) |
49716 |
isopropyl 2-[3-(4-hydroxy-3,5-diiodobenzoyl)-1-benzofuran-2-yl]acetate
|
|
C20H16I2O5 |
详情 |
详情
|
(XV) |
16194 |
2-chloro-N,N-diethyl-1-ethanamine; N-(2-chloroethyl)-N,N-diethylamine
|
100-35-6 |
C6H14ClN |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) The condensation of 2-nitroimidazole (I) with methyl chloroacetate (II) by means of sodium methoxide in methanol - DMF at 150 C gives methyl 2-nitro-1-imidazolylacetate (III), which is then condensed with benzylamine (IV) in methanol.
【1】
Castaner, J.; Roberts, P.J.; Benznidazole. Drugs Fut 1977, 2, 9, 568.
|
【2】
Beaman, A.G.; Duschinsky, R.; Tautz, W.P. (F. Hoffmann-La Roche AG); Novel imidazole derivs. and a process for the manufacture thereof. GB 1138529 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
10258 |
methyl 2-(2-nitro-1H-imidazol-1-yl)acetate; Methyl 2-nitro-1-imidazoleacetate
|
22813-31-6 |
C6H7N3O4 |
详情 | 详情
|
(IV) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(III) Treatment of deoxybenzoin (I) with hydroxylamine hydrochloride produces the corresponding oxime (II). Condensation of the dilithium derivative of (II) with methyl chloroacetate (III) generates the dihydroisoxazole (IV). Subsequent chlorosulfonation of (IV), followed by treatment with ammonia, furnishes sulfonamide (V). Then, displacement of the chloro group of (V) with silver nitrate gives rise to the target nitrate ester. Alternatively, chloride (V) is converted to alcohol (VI) by displacement with formic acid, followed by alkaline hydrolysis. Then, reaction of alcohol (VI) with in situ generated acetyl nitrate yields the corresponding nitrate.
【1】
Schroeder, J.D.; et al.; NMI-1093: A nitric oxide-enhanced cyclooxygenase-2 selective inhibitor with cardioprotective potential. 224th ACS Natl Meet (Aug 18 2002, Boston) 2002, Abst MEDI 316.
|
【2】
Garvey, D.S.; Tam, S.W.; Letts, L.G.; Schroeder, J.D.; Bandarage, U.K.; Fang, X.; Bandarage, R.R. (NitroMed Inc.); Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compsns. and methods of use. WO 0145703 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41003 |
1,2-diphenyl-1-ethanone; Deoxybenzoin-2-phenylacetophenone; Dexybenzoin
|
451-40-1 |
C14H12O |
详情 | 详情
|
(II) |
41004 |
1,2-diphenyl-1-ethanone oxime
|
|
C14H13NO |
详情 |
详情
|
(III) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(IV) |
57848 |
5-(chloromethyl)-3,4-diphenyl-4,5-dihydro-5-isoxazolol
|
|
C16H14ClNO2 |
详情 |
详情
|
(V) |
57849 |
4-[5-(chloromethyl)-3-phenyl-4-isoxazolyl]benzenesulfonamide
|
|
C16H13ClN2O3S |
详情 |
详情
|
(VI) |
57850 |
4-[5-(hydroxymethyl)-3-phenyl-4-isoxazolyl]benzenesulfonamide
|
|
C16H14N2O4S |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(II)
【1】
Hill JH M. 1965. Mechanism of the gabriel-colman rearrangement. J Org Chem, 30: 620~622 |
【2】
Wen YZ, Wei WL, Gao ZW. 2005. Synthesis of meloxicam.中国医药工业杂志.36 (6): 321~322 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
66516 |
methyl 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carboxylate 1,1-dioxide |
35511-14-9 |
C10H9NO5S |
详情 | 详情
|
(I) |
66521 |
|
|
C7H4KN2O3 |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
66522 |
|
|
C10H9N2O5 |
详情 | 详情
|
(V) |
19537 |
methyl 4-hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda(6),2-benzothiazine-3-carboxylate
|
|
C11H11NO5S |
详情 |
详情
|
(VI) |
19538 |
5-Methyl-2-thiazolamine; 5-methyl-1,3-thiazol-2-ylamine; 5-methyl-1,3-thiazol-2-amine; 2-amino-5-methylthiazole
|
7305-71-7 |
C4H6N2S |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II)
【1】
Jansen R, Knopp M, Amberg W, et al. 2001. Structural similarity and its surprises: endothelin receptor antagonists-process research and development report. Org Proc Res Dev, 5(1):16~22. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18732 |
benzophenone
|
119-61-9 |
C13H10O |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
21148 |
methyl 3,3-diphenyl-2-oxiranecarboxylate
|
|
C16H14O3 |
详情 |
详情
|
(IV) |
21149 |
methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate
|
|
C17H18O4 |
详情 |
详情
|
(V) |
21153 |
2-hydroxy-3-methoxy-3,3-diphenylpropionic acid
|
|
C16H16O4 |
详情 |
详情
|
(VI) |
67028 |
(S)-1-(p-tolyl)ethanamine |
27298-98-2 |
C9H13N |
详情 | 详情
|
(VII) |
67029 |
|
|
C16H16O4.C9H13N |
详情 | 详情
|
(VIII) |
21150 |
4,6-dimethoxy-2-(methylsulfonyl)pyrimidine; 4,6-dimethoxy-2-pyrimidinyl methyl sulfone
|
|
C7H10N2O4S |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(IV) Cyclization of 4-cyclopropyl-1-naphthyl isothiocyanate (I) with aminoguanidine hydrochloride (II) using DIEA in DMF yields the naphthyl-1,2,4-triazole-3-thiol (III), which is then alkylated with methyl chloroacetate (IV) by means of K2CO3 in DMF to give the (triazolylsulfanyl)acetate (V). Diazotization of the amine (V) with NaNO2 and Cl2CHCOOH in the presence of BnEt3NBr or BnEt3NCl in CHBr3 gives rise to the 5-bromotriazole derivative (VI), which is hydrolyzed with LiOH in THF/EtOH/H2O to produce lesinurad (VII) , and is finally treated with NaOH in EtOH .
Also, coupling of the thiol (III) with the 2-chloroacetamide derivative (VIII) by means of K2CO3 in DMF yields the amide (IX), which is then brominated with CHBr3 in the presence of NaNO2, Cl2CHCOOH and BnEt3NBr or BnEt3NCl to give the 5-bromotriazole derivative (X) .Finally, hydrolysis of amide (X) with NaOH in refluxing EtOH affords lesinurad (VII) .
【1】
Miner, J., Quart, B.D., Girardet, J.-L. (Ardea Biosciences, Inc.). Treatment of gout. WO 201116852. |
【2】
Quart, B.D., Girardet, J.-L., Gunic, E., Yeh, L.-T. (Ardea Biosciences, Inc.).Novel compounds and composition and methods of use. CA 2706858, CN 01918377, EP 2217577, JP 2011504935, KR 2010085195, US 2009197825, US 2011268801, WO 009070740. |
【3】
Zamansky, I., Galvin, G., Girardet, J.-L. (Ardea Biosciences, Inc.). Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate, and uses thereof. WO 2011085009. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68901 |
4-cyclopropyl-1-naphthyl isothiocyanate |
878671-95-5 |
C14H11NS |
详情 | 详情
|
(II) |
68902 |
aminoguanidine hydrochloride;aminoguanidine monohydrochloride;Hydrazinecarboximidamide |
1937-19-5 |
CH6N4.HCl |
详情 | 详情
|
(III) |
68903 |
5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol |
|
C15H14N4S |
详情 | 详情
|
(IV) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(V) |
68904 |
methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate |
|
C18H18N4O2S |
详情 | 详情
|
(VI) |
68905 |
methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate |
|
C18H16BrN3O2S |
详情 | 详情
|
(VII) |
68906 |
2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
|
C17H14BrN3O2S |
详情 | 详情
|
(VIII) |
68907 |
2-chloro-N-(2-chloro-4-sulfamoylphenyl)acetamide |
|
C8H8Cl2N2O3S |
详情 | 详情
|
(IX) |
68908 |
2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-chloro-4-sulfamoylphenyl)acetamide |
|
C23H21ClN6O3S2 |
详情 | 详情
|
(X) |
68909 |
2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-chloro-4-sulfamoylphenyl)acetamide |
|
C23H19BrClN5O3S2 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(VIII)
【1】
Lopez M,Rodriguez Z,Gonzalez M,et al.Synthesis of (Z)-2-(2-formamido-4-thiazolyl)-2-(substituted alkoxyimino)acetic acids.Farmaco,2000,55:40. |
【2】
Parthasaradhi Reddy B,Rathnakar Reddy K,Raji Reddy R,et al.An improved process for the preparation of ceficime:WO,Patent 2,006,103,686,2006. |
【3】
程先波,胡立蓬,叶树祥,等.头孢克肟的制备方法:CN,Patent 101,319,246,2008. |
【4】
潘行远.一种头孢克肟的合成方法:CN,Patent 101,016,305,2007. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27907 |
Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate |
1694-31-1 |
C8H14O3 |
详情 | 详情
|
(II) |
69635 |
(Z)-tert-butyl 2-(hydroxyimino)-3-oxobutanoate |
|
C8H13NO4 |
详情 |
详情
|
(III) |
69636 |
(Z)-tert-butyl 2-((2-methoxy-2-oxoethoxy)imino)-3-oxobutanoate |
|
C11H17NO6 |
详情 |
详情
|
(IV) |
69637 |
4-Chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid;4-Chloro-2-(Z)-methoxycarbonylmethoxyimino-3-oxobutyric acid;(Z)-4-chloro-2-((2-methoxy-2-oxoethoxy)imino)-3-oxobutanoic acid |
95759-10-7 |
C7H8ClNO6 |
详情 | 详情
|
(V) |
69638 |
(Z)-2-(2-aminothiazol-4-yl)-2-((2-methoxy-2-oxoethoxy)imino)acetic acid |
80544-17-8 |
C8H9N3O5S |
详情 | 详情
|
(VI) |
69639 |
(Z)-methyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)acetate |
246035-38-1 |
C15H12N4O4S3 |
详情 | 详情
|
(VII) |
69640 |
(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-methoxy-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
C17H17N5O7S2 |
详情 |
详情
|
(VIII) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(IX) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(X) |
64882 |
(6R,7R)-7-amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
79349-82-9 |
C9H10N2O3S |
详情 | 详情
|